PUBLISHER: Grand View Research | PRODUCT CODE: 1632611
PUBLISHER: Grand View Research | PRODUCT CODE: 1632611
The global clinical perinatal software market size is expected to reach USD 303.9 million in 2030 and is expected to witness a CAGR of 10.3% from 2025 to 2030. The increasing number of stillbirth cases globally is boosting the market growth.
Integrated software product segment held the largest market share in terms of revenue in 2024. Increasing demand for the workflow integration of medical professionals is anticipated to drive the growth of this segment in the forthcoming years. Moreover, technological advancements and growing adoption are the factors projected to continue fueling the segment growth over the forecast period.
In terms of application, fetal monitoring data services held the largest revenue share in 2024. These services provide accurate and adequate monitoring of fetal heartbeat and uterine contraction. Mobile fetal monitoring allows patients to remotely access the data to track the fetal development. This factor is projected to positively influence the segment growth during the forecast period.
Supportive government initiatives for maintaining maternal health are increasing the adoption of clinical perinatal software. Moreover, adoption and implementation of healthcare IT solutions such as monitoring systems in clinics, hospitals and surgical centers have increased the efficiency of work and reduced healthcare expenditure, thereby propelling the market growth.
The industry players are taking initiatives to develop new software with added data security, thus propelling further growth. For instance, in May 2018 Myriad Genetics acquired Counsyl in order to improve its portfolio in noninvasive prenatal screening.